Page last updated: 2024-09-03

n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and 4-iodoamphetamine

n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine has been researched along with 4-iodoamphetamine in 1 studies

Compound Research Comparison

Studies
(n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine)
Trials
(n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine)
Recent Studies (post-2010)
(n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine)
Studies
(4-iodoamphetamine)
Trials
(4-iodoamphetamine)
Recent Studies (post-2010) (4-iodoamphetamine)
8021100416

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blau, M1

Reviews

1 review(s) available for n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and 4-iodoamphetamine

ArticleYear
Radiotracers for functional brain imaging.
    Seminars in nuclear medicine, 1985, Volume: 15, Issue:4

    Topics: Amphetamines; Animals; Blood-Brain Barrier; Brain; Cerebrovascular Circulation; Deoxyglucose; Fluorine; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Iodobenzenes; Microspheres; Oxygen Radioisotopes; Radioisotopes; Receptors, Cholinergic; Receptors, Dopamine; Receptors, Muscarinic; Technetium; Tomography, Emission-Computed; Xenon Radioisotopes

1985